Govindh Aswin
Driving commercial analytics strategy in pharma’s CVRM & obesity portfolio. Leading zilebesiran market analytics (Roche–Alnylam $3.1B) and supporting CT-388 obesity asset.
- Role
- Senior Analyst at Roche
- Location
- Chennai, TN, IN
- LinkedIn followers
- 500 followers
About Govindh Aswin
I am a Senior Analyst at Roche, a global leader in healthcare and pharmaceuticals. I work collaboratively with stakeholders in the Pipeline teams across Roche’s global affiliates and deliver high quality analytics solutions to real-world business problems.I have a Master of Business Administration degree from St. Joseph\'s Institute of Management Trichy, where I was the overall winner of Jimnesia 20••••20, a grand event that showcased my leadership and teamwork skills. I also have a Bachelor of Science degree in Computer Science from St.Joseph\'s College, Tiruchirappalli, where I honed my programming and data skills.I am proficient in various data languages, tools, and platforms, such as SQL, Python, PySpark, R, C, C++, Tableau, Power BI, Microsoft Excel, R, Google Data Studio, S3, AWS Athena, and Sagemaker. I use these skills to process very large scale secondary healthcare datasets and perform complex analysis to derive insights. I also generate qualitative and quantitative insights reports that communicate the key takeaways in an easy to understand manner.I am passionate about crunching numbers and making data dance to new beats. I help the team prioritize across competing stakeholders requests to ensure focus on activities of highest importance. I am always eager to learn new techniques and technologies to enhance my data analytics capabilities and deliver value to the clients. I am also looking for opportunities to work across continents and cultures, and seek visa sponsorship to achieve this goal.
Experience
Senior Analyst
Aug 2022 — Present · Chennai, IN
Lead commercial pipeline analytics supporting multi-billion-dollar business development and licensing decisions across major therapeutic areas including CVRM, IBD, and Obesity.• Partner with global business development, commercial strategy, and forecasting teams to shape data-driven acquisition decisions and portfolio strategies.• Delivered deep-dive market assessments covering patient journey, HCP behavior, payer dynamics, and competitive landscape to identify unmet opportunities and white spaces.• Played a pivotal role in the $2.7B acquisition of Carmot Therapeutics by providing actionable insights into the obesity treatment landscape and emerging competitor pipeline.• Currently driving analytical evaluations for the potential $7B Televant acquisition, influencing early-stage commercial and R&D integration strategies.• Designed a flexible insights platform that empowers stakeholders to self-serve critical KPIs — including market, patient, and payer-level metrics — enhancing decision agility across teams.• Managed cross-functional ad hoc analytics requests from multiple therapy areas, directly supporting go/no-go investment discussions and long-term asset valuation.
Education
St. Joseph's College (Autonomous), Tiruchirappalli
Bachelor of Science (BSc), Computer Science
2015 — 2018
Sowdambikaa Matriculation School
HSC, Computer Science
2013 — 2015
St.Joseph's Institute of Management-JIM,Trichy
Master of Business Administration - MBA, Business Administration and Management, General
2018 — 2020
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.